| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $55.9M | — | -5.5% |
| Cost of Revenue | $14.3M | — | -7.5% |
| Gross Profit | $41.6M | — | -4.8% |
| R&D Expense | $6.5M | — | -30.1% |
| SG&A Expense | $12.1M | — | -1.5% |
| Operating Income | -$201.3M | — | -8.9% |
| Interest Expense | $2.6M | — | +8.1% |
| Pre-tax Income | -$195.8M | — | -18.0% |
| Income Tax | -$3.4M | — | +68.4% |
| Net Income | -$138.6M | — | -29.3% |
| EPS (Basic) | -$1.32 | — | -38.9% |
| EPS (Diluted) | -$1.32 | — | -38.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $157.6M | -3.7% | +48.6% |
| Short-term Investments | $20.4M | +18.5% | -78.4% |
| Accounts Receivable | $38.9M | -25.1% | -9.3% |
| Current Assets | $245.8M | -4.6% | -10.1% |
| Total Assets | $514.7M | -30.0% | -36.3% |
| Current Liabilities | $140.4M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $11.6M | — | -55.6% |
| Capital Expenditures | $3.2M | — | -58.4% |
| Investing Cash Flow | -$6.2M | — | -107.4% |
| Financing Cash Flow | -$10.9M | — | +90.1% |
| Free Cash Flow | $8.4M | — | -54.5% |
| -10.0% |
| Long-term Debt | $154.0M | -7.4% | -5.2% |
| Total Liabilities | $324.0M | -9.1% | -13.1% |
| Stockholders' Equity | $190.7M | -49.7% | -56.3% |